Status:
COMPLETED
The Use of Platelet-rich-fibrin in Lower Third Molar Surgery.
Lead Sponsor:
Amerigo Giudice
Conditions:
Facial Swelling
Tooth Position Anomalies
Eligibility:
All Genders
18-32 years
Phase:
NA
Brief Summary
The present study aims to analyze the effect of PRF (Platelet-rich-fibrin) in terms of facial swelling, trismus and pain after surgical removal of mandibular third molar (M3M) in a split-mouth randomi...
Detailed Description
The present study aims to analyze the effect of PRF (Platelet-rich-fibrin) in terms of facial swelling, trismus and pain after surgical removal of mandibular third molar (M3M) in a split-mouth randomi...
Eligibility Criteria
Inclusion
- Patients aged 18 to 32 years who required both M3M extractions were recruited
- Good health status
- Indication to surgical extraction of both M3M
- Complete root formation
- Surgical risk level classified as "Conventional" or "Moderate" according to Daugela et al. classification
Exclusion
- Person under the age of 18 or over 32
- Allergy or contraindications to administration of corticosteroids
- Acute infection in any of the teeth to be extracted
- Patients with chronic liver disease, diabetes, immune system dysfunction, or haematological disease
- Pregnancy or breastfeeding
- History of treatment with antiresorptive drugs
- Chronic kidney disease
Key Trial Info
Start Date :
October 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2023
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT06165692
Start Date
October 1 2022
End Date
October 31 2023
Last Update
December 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Magna Graecia University of Catanzaro
Catanzaro, Italy, 88100